APA (7th ed.) Citation

Liu, J. F., Moore, K. N., Birrer, M. J., Berlin, S., Matulonis, U. A., Infante, J. R., . . . Humke, E. W. (2016). Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody-drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancer. Annals of Oncology, 27(11), 2124. https://doi.org/10.1093/annonc/mdw401

Chicago Style (17th ed.) Citation

Liu, J. F., et al. "Phase I Study of Safety and Pharmacokinetics of the Anti-MUC16 Antibody-drug Conjugate DMUC5754A in Patients with Platinum-resistant Ovarian Cancer or Unresectable Pancreatic Cancer." Annals of Oncology 27, no. 11 (2016): 2124. https://doi.org/10.1093/annonc/mdw401.

MLA (9th ed.) Citation

Liu, J. F., et al. "Phase I Study of Safety and Pharmacokinetics of the Anti-MUC16 Antibody-drug Conjugate DMUC5754A in Patients with Platinum-resistant Ovarian Cancer or Unresectable Pancreatic Cancer." Annals of Oncology, vol. 27, no. 11, 2016, p. 2124, https://doi.org/10.1093/annonc/mdw401.